Real-World Evidence of Adherence to Denosumab Therapy and Fracture Risk Associated With Drug Withdrawal: A Cross-sectional Study
CompletedOBSERVATIONAL
Enrollment
210
Participants
Timeline
Start Date
October 1, 2022
Primary Completion Date
May 1, 2023
Study Completion Date
March 1, 2024
Conditions
Osteoporosis
Trial Locations (1)
22030
Trakya University Medical Faculty, Edirne
All Listed Sponsors
lead
Trakya University
OTHER
NCT06414616 - Real-World Evidence of Adherence to Denosumab Therapy and Fracture Risk Associated With Drug Withdrawal: A Cross-sectional Study | Biotech Hunter | Biotech Hunter